This report provides in-depth analysis of the global medical plastics industry. Included is a discussion of market conditions and trends by region, legislative activity that will impact product development, growth opportunities and challenges, and strategies implemented by leading medical device OEMs, and materials suppliers that support the industry.
Key topics covered include issues regarding security and traceability, reprocessed medical devices, thermoplastic compounds, biomaterials, bioresorbables, LSR, the role of 3-D printing and regulatory changes.
You will gain insight and perspectives from these industry thought leaders:
- Harold Faig, CEO, Medplast
- Dr. Stephen Spiegelberg, President & Co-founder, Cambridge Polymer Group
- Len Czuba, President, Czuba Enterprises Inc.
The report also contains in-depth profiles of plastics processors that manufacture products for the sector – with an analysis for each and discussion of key performance indicators and global growth initiatives.
New regulations impacting China's medical device sector is examined and U.S. Government Accountability Office (GAO) data on publicly traded medical device companies is also included:
- Overall net sales: 2005-2014
- Overall net profit or loss figures: 2005-2014
Plastics processor data shows 2010-2014 metrics for:
- Sales revenue
- Number of employees